CLOs on the Move


 
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.my01.io
  • 400 Boul de Maisonneuve Ouest Suite 700
    Montréal, QC CAN H3A 1L4
  • Phone: 855.799.6901

Executives

Name Title Contact Details

Similar Companies

first health care group inc

first health care group inc is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NoIR Laser Company

NoIR Laser Company is a South Lyon, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Medical Electronics Corporation

Advanced Medical Electronics Corporation is a Maple Grove, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sightech Vision Systems

Sightech Vision Systems is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endotronix

Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella™ Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.